Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
Conclusions: A combined index of CD44 and Nanog expression is a promising prognostic predictor of recurrence free survival and overall survival in bladder cancer. It may help identification of patients who will benefit from intensive treatment.
PMID: 31718471 [PubMed - as supplied by publisher]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research
More News: Biomedical Science | Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Laboratory Medicine | Nanotechnology | Science | Stem Cell Therapy | Stem Cells | Study | UK Health